Cipla Limited Budesonide Export Data — India (DGFT 2022–2026)

Name: Cipla Limited Budesonide Export Records India — #1 Exporter, 1,060 Shipments, $53.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-06-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Budesonide

India Pharmaceutical Trade Intelligence

$190.5M275 Suppliers115 CountriesHS 30049099

ExportsIndia → UNITED STATES55.0%India → SAUDI ARABIA15.2%

ImportsITALY → India$229.2M SWEDEN → India$74.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Cipla Limited — Budesonide Exporter #1 | $53.0M Trade Value | TransData Nexus | TransData Nexus

Cipla Limited — Budesonide Exporter Profile

Indian Pharmaceutical Exporter · #1 for Budesonide · $53.0M export value · DGFT Verified

Cipla Limited is the #1 Indian exporter of Budesonide with $53.0M in export value and 1,060 verified shipments. Cipla Limited holds a 27.8% market share in Budesonide exports across 31 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.

Cipla Limited — Budesonide Export Profile: Buyers & Destinations

Cipla Limited Budesonide export treemap — buyers and destination countries | TransData Nexus

Where Does Cipla Limited Export Budesonide?

Country	Value	Shipments	Share
UNITED STATES	$19.0M	412	46.9%
ALGERIA	$5.6M	117	13.7%
UNITED ARAB EMIRATES	$3.5M	75	8.6%
SAUDI ARABIA	$2.7M	65

Who Are the Top Buyers of Budesonide from Cipla Limited?

Buyer	Country	Value	Orders
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$15.9M	331
BIOPHARM DISTRIBUTION SPA	ALGERIA	$3.0M	60
ACINO PHARMACEUTICALS FZ LLC	UNITED ARAB EMIRATES	$2.2M	47
BIOPHARM DISTRIBUTION SPA,	ALGERIA	$1.7M	38
BREATHEFREE LANKA PVT LTD	SRI LANKA	$1.5M	44
CIPLA USA INC UPS SUPPLY CHAIN SOL	UNITED STATES	$1.3M	26
ESPARMA PHARMA SERVICES GMBH	GERMANY	$1.0M	22
TO THE ORDER OF CITIBANK N A ALGERI	ALGERIA	$815.6K	17
EXELAN PHARMACEUTICALS, INC	UNITED STATES	$699.1K	19
BREATHEFREE LANKA PRIVATE LIMITED	SRI LANKA	$651.4K	21

Cipla Limited supplies Budesonide to 101 buyers globally. The largest buyer is CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), followed by BIOPHARM DISTRIBUTION SPA (ALGERIA) and ACINO PHARMACEUTICALS FZ LLC (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Budesonide Formulations Does Cipla Limited Export?

Product Description / Formulation	Value	Shipments
BUDESONIDE INHALATION SUSPENSION 0.5MG/2	$4.5M	91
BUDESONIDE INHALATION SUSPENSION 1MG/2ML	$1.6M	32
BUDECORT 200 INHALER WITH DOSE IDICATOR (BUDESONIDE 200MCG) 1 X 200 MD	$1.0M	21
BUDESONIDE INHALATION SUSPENSION 0.25MG/	$900.0K	18
BUDECORT 0.5 MG RESPULES (BUDESONIDE 0.5	$700.3K	15
BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML; NDC NO. 69097-319-87; ANDA NO. 205710 PACK SIZE 6 X 5 X 2 ML	$650.0K	13
BUDECORT 200 INHALER WITH DOSE IDICATOR BUDESONIDE 200 MCG	$565.6K	12
BUDECORT 200 INHALER WITH DOSE IDICATOR(BUDESONIDE 200 MCG).NOS	$541.1K	12
BUDECORT 200 INHALER WITH DOSE INDICATOR(BUDESONIDE 200 MCG)NOS	$540.2K	12
BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML; NDC NO. 69097-319-87; ANDA NO. 205710 PACK SIZE 6X5X2 MLNOS	$497.5K	12

Cipla Limited exports 480 distinct Budesonide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BUDESONIDE INHALATION SUSPENSION 0.5MG/2 with 91 shipments worth $4.5M.

How Does Cipla Limited Compare to Nearest Budesonide Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED ★	$53.0M	1,060	31	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$7.8M	166	3	$47.1K
3	ZYDUS LIFESCIENCES LIMITED	$2.4M	78	7	$30.9K

Cipla Limited ranks #1 among 275 Indian Budesonide exporters. Average shipment value of $50.0K compared to the market average of $256.7K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Budesonide Exports?

Port	Shipments	% Share
SAHAR AIR	1,990	21.8%
DELHI AIR CARGO ACC (INDEL4)	1,616	17.7%
DELHI AIR	1,404	15.4%
SAHAR AIR CARGO ACC (INBOM4)	1,213	13.3%
Delhi Air	419	4.6%
Bombay Air	386	4.2%
NHAVA SHEVA SEA (INNSA1)	303	3.3%
Delhi Air Cargo	152	1.7%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Budesonide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,060 individual customs records matching Cipla Limited exporting Budesonide, covering 480 formulations to 34 countries via 101 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 609+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Budesonide

Budesonide

Cipla Limited — Budesonide Exporter Profile

Cipla Limited — Budesonide Export Profile: Buyers & Destinations

Where Does Cipla Limited Export Budesonide?

Who Are the Top Buyers of Budesonide from Cipla Limited?

What Is India's Total Budesonide Export Value and How Much Does Cipla Limited Contribute?

What Is the Average Shipment Value for Cipla Limited's Budesonide Exports?

How Does Cipla Limited Compare to Other Indian Budesonide Exporters?

What Budesonide Formulations Does Cipla Limited Export?

Regulatory Requirements: Exporting Budesonide to Key Markets

United States — FDA

How Does Cipla Limited Compare to Nearest Budesonide Exporters?

Which Indian Ports Ship Budesonide Exports?

What Other Respiratory Products Does Cipla Limited Export?

Geopolitical & Trade Policy Impact on Cipla Limited's Budesonide Exports

Cipla Limited — Regulatory Compliance & Quality Standards

About Cipla Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Budesonide Export Data from Cipla Limited

Budesonide Stats

Company Overview

Top Products by Cipla Limited

Related Analysis

Need Detailed Export Data?

Data Source